其中，可溶性C5b-9（sC5b-9）作为末端补体复合物（Terminal Complement Complex, TCC）的循环标志物，已成为评估补体激活程度和治疗效果的关键指标。 然而，现有检测方法存在线性范围窄、抗干扰能力差异大等问题，尤其在使用补体抑制剂（如抗C5单抗Eculizumab）时，不同试剂盒的检测性能可能显著影响临床 ...

Biomarkers can serve as early warning signs for individual health and can help indicate certain diseases.In a new study, researchers examined levels of microvascular C5b-9 (a protein found on the skin ...